New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
10:26 EDTASPXAuspex Systems opens for trade at $15.00, IPO priced at $12.00
Auspex Systems (ASPX) priced 7M shares at $12.00. Stifel and BMO Capital acted as joint book running managers for the offering.
News For ASPX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
14:10 EDTASPXTeva deal yields cash, validation to Concert, says Ladenburg
Subscribe for More Information
10:01 EDTASPXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:27 EDTASPXAuspex Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
Subscribe for More Information
07:25 EDTASPXTeva upgraded at Oppenheimer
Subscribe for More Information
06:19 EDTASPXAuspex Pharmaceuticals downgraded to Hold from Buy at Stifel
Auspex Pharmaceuticals (ASPX) is being acquired by Teva (TEVA) for $101 per share in cash.
06:18 EDTASPXAuspex Pharmaceuticals downgraded to Neutral from Outperform at RW Baird
Auspex Pharmaceuticals (ASPX) is being acquired by Teva (TEVA) for $101 per share in cash.
March 30, 2015
16:22 EDTASPXOn The Fly: Closing Wrap
Subscribe for More Information
13:32 EDTASPXAuspex downgraded to Market Perform from Outperform at William Blair
Subscribe for More Information
13:11 EDTASPXTeva made 'bold move' with Auspex deal, says BMO Capital
Subscribe for More Information
12:22 EDTASPXOn The Fly: Midday Wrap
Subscribe for More Information
11:49 EDTASPXAuspex downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
10:16 EDTASPXAuspex Pharmaceuticals downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
09:27 EDTASPXOn The Fly: Pre-market Movers
Subscribe for More Information
09:15 EDTASPXTeva does not rule out bigger deal if opportunity arises
Subscribe for More Information
09:02 EDTASPXMylan slips amid Abbott share sale, Teva deal for Auspex
Subscribe for More Information
08:42 EDTASPXTeva says has capacity for additional acquisitions after Auspex deal
Teva (TEVA) says the Auspex (ASPX) transaction is not subject to shareholder approval. Comments from Teva CFO Eyal Desheh speaking on the Teva/Auspex conference call regarding the companies' transaction announced this morning.
07:03 EDTASPXTeva: Auspex deal represents total consideration of $3.2B in enterprise value
Subscribe for More Information
07:01 EDTASPXTeva to acquire Auspex Pharmaceuticals for $101 per share in cash
Subscribe for More Information
07:00 EDTASPXTeva to acquire Auspex Pharmaceuticals for $101 per share in cash

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use